100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Previously searched by you
Previously searched by you
logo
FULL TEST BANK PHARMACOLOGY AND THE NURSING PROCESS 9TH EDITION By Linda Lane Lilley| Shelly Rainforth Collins| Snyder CA$23.10   Add to cart
Quickly navigate to
Preview
  2.  
  3. PHARMACOLOGY AND THE NURSING PROCESS 9TH EDITION
  4.  
  5. PHARMACOLOGY AND THE NURSING PROCESS 9TH EDITION

Exam (elaborations)

FULL TEST BANK PHARMACOLOGY AND THE NURSING PROCESS 9TH EDITION By Linda Lane Lilley| Shelly Rainforth Collins| Snyder
 15 views  0 purchase
  • Course
  • PHARMACOLOGY AND THE NURSING PROCESS 9TH EDITION
  • Institution
  • PHARMACOLOGY AND THE NURSING PROCESS 9TH EDITION
  • Book
  • Pharmacology and the Nursing Process

FULL TEST BANK PHARMACOLOGY AND THE NURSING PROCESS 9TH EDITION By Linda Lane Lilley| Shelly Rainforth Collins| Snyder FULL TEST BANK PHARMACOLOGY AND THE NURSING PROCESS 9TH EDITION By Linda Lane Lilley| Shelly Rainforth Collins| Snyder

Preview 4 out of 368  pages

Document information

  • September 25, 2024
  • 368
  • 2024/2025
  • Exam (elaborations)
  • Questions & answers

Subjects

  • pharmacology
  • nursing process
  • 9th edition

Connected book

book image

Book Title:

Author(s):

  • Edition:
  • ISBN:
  • Edition:

More summaries for

  • Test Bank for Pharmacology and the Nursing Process 9th Edition Linda Lilley Shelly Collins Julie Snyder Complete Guide A+ ISBN:9780323529495 Newest 2024 Version
  • Test Bank: Pharmacology and the Nursing Process, 9th Edition by Lilley - Chapters 1-58,
  • TEST BANK FOR PHARMACOLOGY AND THE NURSING PROCESS 8TH EDITION BY LILLEY || All Chapters || Complete Solution.
All for this textbook (282)

Written for

  • PHARMACOLOGY AND THE NURSING PROCESS 9TH EDITION
  • PHARMACOLOGY AND THE NURSING PROCESS 9TH EDITION

Seller

avatar-seller
NurseJanetteRichardson

Reviews received

Content preview

FULL TEST BANK
PHARMACOLOGY AND THE NURSING PROCESS 9TH EDITION
____________________________________________________________________________________

By Linda Lane Lilley| Shelly Rainforth Collins| Snyder

,Table of Contents
PART 1: PHARMACOLOGY BASICS ................................................................................................................. 4
CHAPTER 01: THE NURSING PROCESS AND DRUG THERAPY .................................................................... 4
CHAPTER 02: PHARMACOLOGIC PRINCIPLES ............................................................................................ 8
CHAPTER 03: LIFESPAN CONSIDERATIONS ............................................................................................. 16
CHAPTER 04: CULTURAL, LEGAL, AND ETHICAL CONSIDERATIONS ........................................................ 23
CHAPTER 05: MEDICATION ERRORS: PREVENTING AND RESPONDING ................................................. 30
CHAPTER 06: PATIENT EDUCATION AND DRUG THERAPY ...................................................................... 34
CHAPTER 07: OVER-THE-COUNTER DRUGS AND HERBAL AND DIETARY SUPPLEMENTS ....................... 39
CHAPTER 08: GENE THERAPY AND PHARMACOGENOMICS ................................................................... 44
CHAPTER 09: PHOTO ATLAS OF DRUG ADMINISTRATION ...................................................................... 47
PART 2: DRUGS AFFECTING THE CENTRAL NERVOUS SYSTEM ................................................................... 58
CHAPTER 10: ANALGESIC DRUGS ............................................................................................................ 58
CHAPTER 11: GENERAL AND LOCAL ANESTHETICS ................................................................................. 66
CHAPTER 12: CENTRAL NERVOUS SYSTEM DEPRESSANTS AND MUSCLE RELAXANTS ........................... 70
CHAPTER 13: CENTRAL NERVOUS SYSTEM STIMULANTS AND RELATED DRUGS ................................... 76
CHAPTER 14: ANTIEPILEPTIC DRUGS ...................................................................................................... 81
CHAPTER 15: ANTIPARKINSON DRUGS ................................................................................................... 87
CHAPTER 16: PSYCHOTHERAPEUTIC DRUGS........................................................................................... 93
CHAPTER 17: SUBSTANCE USE DISORDER ............................................................................................ 101
PART 3: DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM........................................................... 107
CHAPTER 18: ADRENERGIC DRUGS ....................................................................................................... 107
CHAPTER 19: ADRENERGIC-BLOCKING DRUGS ..................................................................................... 113
CHAPTER 20: CHOLINERGIC DRUGS ...................................................................................................... 119
CHAPTER 21: CHOLINERGIC-BLOCKING DRUGS .................................................................................... 125
PART 4: DRUGS AFFECTING THE CARDIOVASCULAR AND RENAL SYSTEMS ............................................. 131
CHAPTER 22: ANTIHYPERTENSIVE DRUGS ............................................................................................ 131
CHAPTER 23: ANTIANGINAL DRUGS ..................................................................................................... 138
CHAPTER 24: HEART FAILURE DRUGS ................................................................................................... 145
CHAPTER 25: ANTIDYSRHYTHMIC DRUGS ............................................................................................ 151
CHAPTER 26: COAGULATION MODIFIER DRUGS .................................................................................. 158
CHAPTER 27: ANTILIPEMIC DRUGS ....................................................................................................... 165
CHAPTER 28: DIURETIC DRUGS ............................................................................................................. 171

, CHAPTER 29: FLUIDS AND ELECTROLYTES ............................................................................................ 177
PART 5: DRUGS AFFECTING THE ENDOCRINE AND REPRODUCTIVE SYSTEMS ......................................... 184
CHAPTER 30: PITUITARY DRUGS ........................................................................................................... 184
CHAPTER 31: THYROID AND ANTITHYROID DRUGS .............................................................................. 188
CHAPTER 32: DIABETES DRUGS ............................................................................................................ 194
CHAPTER 33: ADRENAL DRUGS ............................................................................................................. 204
CHAPTER 34: WOMEN’S HEALTH DRUGS ............................................................................................. 209
CHAPTER 35: MEN’S HEALTH DRUGS.................................................................................................... 218
PART 6: DRUGS AFFECTING THE RESPIRATORY SYSTEM .......................................................................... 223
CHAPTER 36: ANTIHISTAMINES, DECONGESTANTS, ANTITUSSIVES, AND EXPECTORANTS ................. 223
CHAPTER 37: RESPIRATORY DRUGS ...................................................................................................... 229
PART 7: ANTIINFECTIVE AND ANTIINFLAMMATORY DRUGS .................................................................... 236
CHAPTER 38: ANTIBIOTICS PART 1 ........................................................................................................ 236
CHAPTER 39: ANTIBIOTICS PART 2 ........................................................................................................ 244
CHAPTER 40: ANTIVIRAL DRUGS ........................................................................................................... 250
CHAPTER 41: ANTITUBERCULAR DRUGS............................................................................................... 256
CHAPTER 42: ANTIFUNGAL DRUGS ....................................................................................................... 261
CHAPTER 43: ANTIMALARIAL, ANTIPROTOZOAL, AND ANTHELMINTIC DRUGS ................................... 267
CHAPTER 44: ANTI-INFLAMMATORY AND ANTIGOUT DRUGS ............................................................. 272
PART 8: CHEMOTHERAPEUTIC DRUGS AND BIOLOGIC AND IMMUNE MODIFIERS ................................. 279
CHAPTER 45: ANTINEOPLASTIC DRUGS PART 1: CANCER OVERVIEW AND CELL CYCLE–SPECIFIC DRUGS
.............................................................................................................................................................. 279
CHAPTER 46: ANTINEOPLASTIC DRUGS PART 2: CELL CYCLE–NONSPECIFIC DRUGS AND
MISCELLANEOUS DRUGS ...................................................................................................................... 286
CHAPTER 47: BIOLOGIC RESPONSE–MODIFYING AND ANTIRHEUMATIC DRUGS ................................ 292
CHAPTER 48: IMMUNOSUPPRESSANT DRUGS ..................................................................................... 297
CHAPTER 49: IMMUNIZING DRUGS ...................................................................................................... 303
PART 9: DRUGS AFFECTING THE GASTROINTESTINAL SYSTEM AND NUTRITION ..................................... 308
CHAPTER 50: ACID-CONTROLLING DRUGS ........................................................................................... 309
CHAPTER 51: BOWEL DISORDER DRUGS............................................................................................... 316
CHAPTER 52: ANTIEMETIC AND ANTINAUSEA DRUGS ......................................................................... 325
CHAPTER 53: VITAMINS AND MINERALS .............................................................................................. 331
CHAPTER 54: ANEMIA DRUGS............................................................................................................... 337
CHAPTER 55: NUTRITIONAL SUPPLEMENTS ......................................................................................... 345

, PART 10: DERMATOLOGIC, OPHTHALMIC, AND OTIC DRUGS .................................................................. 351
CHAPTER 56: DERMATOLOGIC DRUGS ................................................................................................. 351
CHAPTER 57: OPHTHALMIC DRUGS ...................................................................................................... 358
CHAPTER 58: OTIC DRUGS .................................................................................................................... 364



PART 1: PHARMACOLOGY BASICS
CHAPTER 01: THE NURSING PROCESS AND DRUG THERAPY

MULTIPLE CHOICE

1. THE NURSE IS WRITING A NURSING DIAGNOSIS FOR A PLAN OF CARE FOR A PATIENT WHO HAS
BEEN NEWLY DIAGNOSED WITH TYPE 2 DIABETES. WHICH STATEMENT REFLECTS THE CORRECT FORMAT
FOR A NURSING DIAGNOSIS?

A. ANXIETY

B. ANXIETY RELATED TO NEW DRUG THERAPY

C. ANXIETY RELATED TO ANXIOUS FEELINGS ABOUT DRUG THERAPY, AS EVIDENCED BY
STATEMENTS SUCH AS “I’M UPSET ABOUT HAVING TO TEST MY BLOOD SUGARS.”

D. ANXIETY RELATED TO NEW DRUG THERAPY, AS EVIDENCED BY STATEMENTS SUCH AS “I’M
UPSET ABOUT HAVING TO TEST MY BLOOD SUGARS.”

CORRECT ANS>D

FORMULATION OF NURSING DIAGNOSES IS USUALLY A THREE-STEP PROCESS. “ANXIETY” IS MISSING
THE “RELATED TO” AND “AS EVIDENCED BY” PORTIONS OF DEFINING CHARACTERISTICS. “ANXIETY
RELATED TO NEW DRUG THERAPY” IS MISSING THE “AS EVIDENCED BY” PORTION OF DEFINING
CHARACTERISTICS. THE STATEMENT BEGINNING “ANXIETY RELATED TO ANXIOUS FEELINGS” IS
INCORRECT BECAUSE THE “RELATED TO” SECTION IS SIMPLY A RESTATEMENT OF THE PROBLEM
“ANXIETY,” NOT A SEPARATE FACTOR RELATED TO THE RESPONSE.

DIF: COGNITIVE LEVEL: UNDERSTANDING (COMPREHENSION) TOP: NURSING PROCESS: NURSING
DIAGNOSIS

MSC: NCLEX: SAFE AND EFFECTIVE CARE ENVIRONMENT: MANAGEMENT OF CARE

2. THE PATIENT IS TO RECEIVE ORAL GUAIFENESIN (MUCINEX) TWICE A DAY. TODAY, THE NURSE
WAS BUSY AND GAVE THE MEDICATION 2 HOURS AFTER THE SCHEDULED DOSE WAS DUE. WHAT TYPE
OF PROBLEM DOES THIS REPRESENT?

A. “RIGHT TIME”

B. “RIGHT DOSE”

C. “RIGHT ROUTE”

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller NurseJanetteRichardson. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for CA$23.10. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

75323 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling

Recently viewed by you

Package deal ·

(0)

Voedings- en beweegcoach Blok 1 en 2

CA$23.10
  • (0)
  Add to cart